| 1 | CLN10, CTSD
|
| Therapeutic Approaches to the Challenge of Neuronal Ceroid Lipofuscinoses.
|
| Kohan R, Cismondi IA, Oller-Ramirez AM, Guelbert N, Anzolini TV, Alonso G, Mole SE, de Kremer DR, de Halac NI.
|
| Curr Pharm Biotechnol urr Pharm Biotechnol. 2011 Jan 11. [Epub ahead of print]
2011
|
| 2 | CLN1, CLN10, CLN2, CLN3, CLN5, CLN6, CLN7, CLN8
|
| The function of CLN3P, the Batten disease protein.
|
| Rakheja D, Narayan SB, Bennett MJ.
|
| Mol Genet Metab 93(3):269-74. Review. No abstract available. Erratum in: Mol Genet Metab. 2008 Jun;94(2):270.
2008
|
| 3 | CTSD, CLN10
|
| Cathepsin d deficiency is associated with a human neurodegenerative disorder.
|
| Steinfeld R, Reinhardt K, Schreiber K, Hillebrand M, Kraetzner R, Bruck W, Saftig P, Gartner J.
|
| Am J Hum Genet 78(6):988-98. Epub 2006 Mar 29. 2006
|
| 4 | CTSD, CLN10
|
| Cathepsin D deficiency underlies congenital human neuronal ceroid-lipofuscinosis.
|
| Siintola E, Partanen S, Stršmme P, Haapanen A, Haltia M, Maehlen J, Lehesjoki AE, TyynelŠ J.
|
| Brain 129(Pt 6):1438-45. Epub 2006 May 2. 2006
|